Close
Almac
Achema middle east

Articles

The Arrival of Quality by Design in Logistics

Quality by Design (QbD) is a concept that has become mainstream in the pharmaceutical manufacturing space in recent years. QbD is a science- and risk-based approach to quality that identities, measures and defines the critical processes that impact quality and...

Top Loading Autoclaves for Labs on a Budget

The QCS EV 100 litre top loading autoclave is among the most space-efficient sterilisers available and will appeal to lab managers for their superior loading capability. They easily accommodate the tallest flasks, fermentors, and bioreactors, but...

Overcoming the Challenges and Complexities of the Personalized Medicine Supply Chain

The last decade has seen an increased emphasis on research and development into personalized medicines, including cell, gene and immunotherapy treatments A trend that is expected to continue due to the forecasted 8.74% CAGR of the personalized medicine,targeted therapeutics, and companion diagnostics market...

High Barrier Containers Meet New Standards in Healthcare Packaging

Today, the chief purpose of primary packaging is product protection. However this performance capability has become more challenging in recent years as the complexity of active pharmaceuticals and their supply chain increases. There are many choices when considering material selection,...

Establishing a high throughput screen of drug solubility in pharmaceutical excipients

At the discovery and early stages of drug development, the aim is to evaluate the pharmacology, pharmacokinetics and toxicology of a compound using a simple liquid formulation. During this process, drugs must dissolve at a concentration high enough to allow...

A Scapegoat for Site Payment Challenges

Managing site payments is not an easy task. They are frustrating, burdensome and a drain of time and resources. CROs, specifically project managers, are often tasked by their sponsor partners to manage the site payment process and consequently are deemed...

Overcoming the challenges of clinical trial recruitment using big data technologies

The problem defined: Any prospective new drug must successfully pass a succession of three clinical trials phases, before it can apply for market approval. These trials represent a significant investment for a pharma company and, as they are prone to delays...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »